CARDOSO, R., F. GUO, T. HEISSER, M. HACKL, P. IHLE, H. DE SCHUTTER, N. VAN DAMME, Z. VALERIANOVA, T. ATANASOV, Ondřej MÁJEK, Jan MUŽÍK, M. C. NILBERT, A. J. TYBJERG, K. INNOS, M. MAGI, N. MALILA, A. M. BOUVIER, V. BOUVIER, G. LAUNOY, A. S. WORONOFF, M. CARIOU, M. ROBASZKIEWICZ, P. DELAFOSSE, F. PONCET, A. KATALINIC, P. M. WALSH, C. SENORE, S. ROSSO, I. VINCERZEVSKIENE, V. E. P. P. LEMMENS, M. A. G. ELFERINK, T. B. JOHANNESEN, H. KORNER, F. PFEFFER, M. J. BENTO, J. RODRIGUES, F. A. DA COSTA, A. MIRANDA, V. ZADNIK, T. ZAGAR, A. L. D. MARQUES, R. MARCOS-GRAGERA, M. PUIGDEMONT, J. GALCERAN, M. CARULLA, M. D. CHIRLAQUE, M. BALLESTA, K. SUNDQUIST, J. SUNDQUIST, M. WEBER, A. JORDAN, C. HERRMANN, M. MOUSAVI, A. RYZHOV, M. HOFFMEISTER and H. BRENNER. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study. Lancet Oncology. New York: Elsevier Science INC, 2021, vol. 22, No 7, p. 1002-1013. ISSN 1470-2045. Available from: https://dx.doi.org/10.1016/S1470-2045(21)00199-6.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study
Authors CARDOSO, R., F. GUO, T. HEISSER, M. HACKL, P. IHLE, H. DE SCHUTTER, N. VAN DAMME, Z. VALERIANOVA, T. ATANASOV, Ondřej MÁJEK (203 Czech Republic, belonging to the institution), Jan MUŽÍK (203 Czech Republic, belonging to the institution), M. C. NILBERT, A. J. TYBJERG, K. INNOS, M. MAGI, N. MALILA, A. M. BOUVIER, V. BOUVIER, G. LAUNOY, A. S. WORONOFF, M. CARIOU, M. ROBASZKIEWICZ, P. DELAFOSSE, F. PONCET, A. KATALINIC, P. M. WALSH, C. SENORE, S. ROSSO, I. VINCERZEVSKIENE, V. E. P. P. LEMMENS, M. A. G. ELFERINK, T. B. JOHANNESEN, H. KORNER, F. PFEFFER, M. J. BENTO, J. RODRIGUES, F. A. DA COSTA, A. MIRANDA, V. ZADNIK, T. ZAGAR, A. L. D. MARQUES, R. MARCOS-GRAGERA, M. PUIGDEMONT, J. GALCERAN, M. CARULLA, M. D. CHIRLAQUE, M. BALLESTA, K. SUNDQUIST, J. SUNDQUIST, M. WEBER, A. JORDAN, C. HERRMANN, M. MOUSAVI, A. RYZHOV, M. HOFFMEISTER and H. BRENNER (guarantor).
Edition Lancet Oncology, New York, Elsevier Science INC, 2021, 1470-2045.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 54.433
RIV identification code RIV/00216224:14110/21:00121970
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/S1470-2045(21)00199-6
UT WoS 000668269600045
Keywords in English colorectal cancer; incidence; mortality; stage distribution; Europe
Tags 14119612, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 23/7/2021 13:32.
Abstract
Findings In countries with long-standing programmes of screening colonoscopy and faecal tests (ie, Austria, the Czech Republic, and Germany), colorectal cancer incidence decreased substantially over time, with AAPCs ranging from -2 center dot 5% (95% CI -2 center dot 8 to -2 center dot 2) to -1 center dot 6% (-2 center dot 0 to -1 center dot 2) in men and from -2 center dot 4% (-2 center dot 7 to -2 center dot 1) to -1 center dot 3% (-1 center dot 7 to -0 center dot 9) in women. In countries where screening programmes were implemented during the study period, age-standardised colorectal cancer incidence either remained stable or increased up to the year screening was implemented. AAPCs for these countries ranged from -0 center dot 2% (95% CI -1 center dot 4 to 1 center dot 0) to 1 center dot 5% (1 center dot 1 to 1 center dot 8) in men and from -0 center dot 5% (-1 center dot 7 to 0 center dot 6) to 1 center dot 2% (0 center dot 8 to 1 center dot 5) in women. Where high screening coverage and uptake were rapidly achieved (ie, Denmark, the Netherlands, and Slovenia), age-standardised incidence rates initially increased but then subsequently decreased. Conversely, colorectal cancer incidence increased in most countries where no large-scale screening programmes were available (eg, Bulgaria, Estonia, Norway, and Ukraine), with AAPCs ranging from 0 center dot 3% (95% CI 0 center dot 1 to 0 center dot 5) to 1 center dot 9% (1 center dot 2 to 2 center dot 6) in men and from 0 center dot 6% (0 center dot 4 to 0 center dot 8) to 1 center dot 1% (0 center dot 8 to 1 center dot 4) in women. The largest decreases in colorectal cancer mortality were seen in countries with long-standing screening programmes.
PrintDisplayed: 18/7/2024 10:33